SUZANNE PAIGE: Open Payments
NPI 1538649157 · LADY LAKE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,631 in 121 payments from 42 companies in 2025. Trend: 2023 $2,540 · 2024 $3,137 · 2025 $2,631
Food & beverage: $2,631
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 10 | $234 |
| AstraZeneca Pharmaceuticals LP | 8 | $226 |
| Novartis Pharmaceuticals Corporation | 12 | $178 |
| Merck Sharp & Dohme LLC | 6 | $140 |
| Eisai Inc. | 7 | $139 |
| GENZYME CORPORATION | 5 | $117 |
| Incyte Corporation | 6 | $114 |
| Geron Corporation | 4 | $98 |
| E.R. Squibb & Sons, L.L.C. | 4 | $93 |
| Astellas Pharma US Inc | 5 | $92 |
Products named: Lenvima, IMFINZI, SARCLISA, KEYTRUDA, RYTELO, BRUKINSA, KISQALI, IBRANCE.
Industry payments across FL — which companies pay providers there.
